These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 34112473

  • 21. Biologics in Chronic Urticaria.
    Bulkhi A, Cooke AJ, Casale TB.
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):95-112. PubMed ID: 27886913
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses.
    Bernstein JA, Ziaie N, Criado R, Criado PR, Rea S, Davis M.
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2251-2263. PubMed ID: 37380071
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Not Available].
    Svendsen SV, Lange NG, Christensen MJ, Mørtz CG, Bindslev-Jensen C.
    Ugeskr Laeger; 2023 Dec 04; 185(49):. PubMed ID: 38078471
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
    Serarslan G, Uzun M, Doğramacı AÇ, Çelik E.
    Dermatol Ther; 2019 Jan 04; 32(1):e12752. PubMed ID: 30238582
    [Abstract] [Full Text] [Related]

  • 31. The Expanding Field of Biologics in the Management of Chronic Urticaria.
    Joshi S, Khan DA.
    J Allergy Clin Immunol Pract; 2017 Jan 04; 5(6):1489-1499. PubMed ID: 28734860
    [Abstract] [Full Text] [Related]

  • 32. Current and future therapies for the treatment of histamine-induced angioedema.
    James C, Bernstein JA.
    Expert Opin Pharmacother; 2017 Feb 04; 18(3):253-262. PubMed ID: 28081650
    [Abstract] [Full Text] [Related]

  • 33. Omalizumab for the treatment of chronic urticaria.
    Zuberbier T, Maurer M.
    Expert Rev Clin Immunol; 2015 Feb 04; 11(2):171-80. PubMed ID: 25566680
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Itch in Urticaria Management.
    Deza G, Giménez-Arnau AM.
    Curr Probl Dermatol; 2016 Feb 04; 50():77-85. PubMed ID: 27578075
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.
    Maurer M, Sofen H, Ortiz B, Kianifard F, Gabriel S, Bernstein JA.
    J Eur Acad Dermatol Venereol; 2017 Jun 04; 31(6):1056-1063. PubMed ID: 27911016
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Angioedema.
    Hahn J, Hoffmann TK, Bock B, Nordmann-Kleiner M, Trainotti S, Greve J.
    Dtsch Arztebl Int; 2017 Jul 24; 114(29-30):489-496. PubMed ID: 28818177
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.